1. Home
  2. HXHX vs XBIO Comparison

HXHX vs XBIO Comparison

Compare HXHX & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haoxin Holdings Limited Class A Ordinary Shares

HXHX

Haoxin Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$0.19

Market Cap

4.7M

Sector

Industrials

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$1.93

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HXHX
XBIO
Founded
2003
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
4.7M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
HXHX
XBIO
Price
$0.19
$1.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.6M
22.2K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.52
EPS
★ N/A
N/A
Revenue
N/A
★ $2,976,411.00
Revenue This Year
N/A
$2.37
Revenue Next Year
N/A
N/A
P/E Ratio
$1.96
★ N/A
Revenue Growth
N/A
★ 19.04
52 Week Low
$0.19
$1.85
52 Week High
$1.36
$4.94

Technical Indicators

Market Signals
Indicator
HXHX
XBIO
Relative Strength Index (RSI) 20.09 32.29
Support Level N/A N/A
Resistance Level $0.56 $2.53
Average True Range (ATR) 0.04 0.12
MACD -0.01 0.03
Stochastic Oscillator 3.75 11.03

Price Performance

Historical Comparison
HXHX
XBIO

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is a China-based logistics company engaged in temperature-controlled transportation and urban delivery services. The company provides cold chain logistics, freight forwarding, and related transportation services for goods, including new energy materials, electronic products, pharmaceuticals, meat, fruits, and vegetables. Its principal revenue streams are temperature-controlled truckload services and urban delivery services.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Share on Social Networks: